Abstract
Inebilizumab (Uplizna (TM); inebilizumab-cdon in the USA) is a humanised anti-CD19 monoclonal antibody being developed by Viela Bio for the treatment ......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
